Sep 09, 2019 - The following slide deck was published by Amgen Inc. in conjunction with this event.
Sep 10, 2019 - Horizon (HZNP) announces the FDA has accepted the Biologics License Application (BLA) for teprotumumab, for the treatment of active thyroid eye disease, and granted it Priority Review designation.
Sep 10, 2019 - Companies In The News Are: T,AA,AMGN,BA
Sep 11, 2019 - Ultragenyx (RARE) and partner Kyowa Kirin plan to submit an sBLA to the FDA for the label expansion of Crysvita.
Sep 12, 2019 - The FDA accepts for review Puma Biotech's (PBYI) sNDA that seeks an approval for Nerlynx in combination with Roche's Xeloda for treating third-line breast cancer.
Sep 16, 2019 - Amgen's (AMGN) phase III study on Kyprolis in combination with dexamethasone and J&J's Darzalex meets the goal of progression-free survival for treating relapsed or refractory multiple myeloma.
Sep 19, 2019 - Alexion's (ALXN) shares decline, following the news of the departure of its current chief financial officer, Paul Clancy.
Sep 20, 2019 - We highlight a few key biotech stocks that surpass the sector so far in 2019 and are likely to witness a winning run in the near term.
Sep 20, 2019 - Here are 5 companies with proven track records.
Sep 25, 2019 - Key highlights of the past week include regulatory and pipeline updates, licensing deals, and more.